Cinepazet
Chemical compound
- C01DX14 (WHO)
- Ethyl 2-{4-[(2Z)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl}acetate
- 23887-41-4
- 6434395
- 4939323
- 0LC95WWE9Q
- ChEMBL2110784
- DTXSID901119699 DTXSID20878521, DTXSID901119699
- Interactive image
- CCOC(=O)CN1CCN(CC1)C(=O)\C=C\c2cc(OC)c(OC)c(OC)c2
InChI
- InChI=1S/C20H28N2O6/c1-5-28-19(24)14-21-8-10-22(11-9-21)18(23)7-6-15-12-16(25-2)20(27-4)17(13-15)26-3/h6-7,12-13H,5,8-11,14H2,1-4H3/b7-6+
- Key:XDUOTWNXVDBCDY-VOTSOKGWSA-N
Cinepazet is a vasodilator and is an ethyl ester derivative of cinepazic acid.[1]
References
- ^ Morton IK, Hall JM (1999). "Cinepazet". Concise Dictionary of Pharmacological Agents : Properties and Synonyms. Dordrecht: Springer Netherlands. p. 77. ISBN 9789401144391.
- v
- t
- e
Vasodilators used in cardiac diseases (C01D)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e